Literature DB >> 23955084

The role of miR-150 in normal and malignant hematopoiesis.

Y He1, X Jiang2, J Chen2.   

Abstract

MicroRNAs are a class of small non-coding RNAs that have been implicated to mediate gene regulation in virtually all important biological processes. Recently there is accumulating evidence showing that miR-150 has essential regulatory roles in both normal and malignant hematopoiesis and holds great potential as a therapeutic target in treating various types of hematopoietic malignancies. The purpose of this review is to summarize our current knowledge about the expression patterns, biological functions and regulatory mechanisms of miR-150 in normal and malignant hematopoiesis, and to highlight the important questions to be answered in this burgeoning field.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23955084     DOI: 10.1038/onc.2013.346

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  55 in total

1.  Syngeneic red blood cell-induced extracellular vesicles suppress delayed-type hypersensitivity to self-antigens in mice.

Authors:  Katarzyna Nazimek; Eugenio Bustos-Morán; Noelia Blas-Rus; Bernadeta Nowak; Włodzimierz Ptak; Philip W Askenase; Francisco Sánchez-Madrid; Krzysztof Bryniarski
Journal:  Clin Exp Allergy       Date:  2019-08-26       Impact factor: 5.018

2.  Role of microRNA-150 in solid tumors.

Authors:  Fang Wang; Xiubao Ren; Xinwei Zhang
Journal:  Oncol Lett       Date:  2015-04-30       Impact factor: 2.967

Review 3.  Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.

Authors:  Sho Ikeda; Hiroyuki Tagawa
Journal:  Int J Hematol       Date:  2014-02-25       Impact factor: 2.490

4.  ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.

Authors:  A Dzikiewicz-Krawczyk; K Kok; I Slezak-Prochazka; J-L Robertus; J Bruining; M M Tayari; B Rutgers; D de Jong; J Koerts; A Seitz; J Li; B Tillema; J E Guikema; I M Nolte; A Diepstra; L Visser; J Kluiver; A van den Berg
Journal:  Leukemia       Date:  2017-03-23       Impact factor: 11.528

5.  Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.

Authors:  Basile Stamatopoulos; Michaël Van Damme; Emerence Crompot; Barbara Dessars; Hakim El Housni; Philippe Mineur; Nathalie Meuleman; Dominique Bron; Laurence Lagneaux
Journal:  Mol Med       Date:  2015-01-09       Impact factor: 6.354

6.  Association between occupational exposure to trichloroethylene and serum levels of microRNAs: a cross-sectional molecular epidemiology study in China.

Authors:  Kyoung-Mu Lee; Bryan A Bassig; Luoping Zhang; Roel C Vermeulen; Wei Hu; Jason Y Y Wong; Chuangyi Qiu; Cuiju Wen; Yongshun Huang; Mark P Purdue; Bu-Tian Ji; Laiyu Li; Xiaojiang Tang; Nathaniel Rothman; Martyn T Smith; Qing Lan
Journal:  Int Arch Occup Environ Health       Date:  2019-06-03       Impact factor: 3.015

7.  Integrated microRNA and mRNA network analysis of the human myometrial transcriptome in the transition from quiescence to labor.

Authors:  William E Ackerman; Irina A Buhimschi; Douglas Brubaker; Sean Maxwell; Kara M Rood; Mark R Chance; Hongwu Jing; Sam Mesiano; Catalin S Buhimschi
Journal:  Biol Reprod       Date:  2018-06-01       Impact factor: 4.285

8.  miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia.

Authors:  Estrella Gonzales-Aloy; Patrick Connerty; Basit Salik; Bing Liu; Andrew J Woo; Michelle Haber; Murray D Norris; Jianlong Wang; Jenny Y Wang
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

9.  Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.

Authors:  Coralie Hoareau-Aveilla; Thibaud Valentin; Camille Daugrois; Cathy Quelen; Géraldine Mitou; Samuel Quentin; Jinsong Jia; Salvatore Spicuglia; Pierre Ferrier; Monica Ceccon; Sylvie Giuriato; Carlo Gambacorti-Passerini; Pierre Brousset; Laurence Lamant; Fabienne Meggetto
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

10.  Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1.

Authors:  Liren Zhang; Jing Lin; Yuanqing Ye; Taro Oba; Emanuela Gentile; Jie Lian; Jing Wang; Yang Zhao; Jian Gu; Ignacio I Wistuba; Jack A Roth; Lin Ji; Xifeng Wu
Journal:  Clin Pharmacol Ther       Date:  2017-10-16       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.